Business Description
Sudeep Pharma Ltd
SIC : 2833
ISIN : INE0QPI01025
Total Employee Number:
651Compare
Compare
Traded in other countries / regions
544619.India IPO Date
2025-11-28Description
Sudeep Pharma Ltd is engaged in the business of manufacturing and selling pharmaceutical and nutraceutical products and intermediaries used by the pharmaceutical and nutraceutical industries globally. It operates through the Pharmaceutical, Food and Nutrition segment, which generates maximum revenue, and the Speciality Ingredients segment. The Pharmaceutical, Food and Nutrition segment pertains to the manufacturing of pharmaceutical excipients and functional food ingredients. The Speciality Ingredients segment pertains to the manufacturing of specialty ingredients using technology to produce micronutrient premixes, liposomal ingredients, encapsulated ingredients, spray-dried ingredients, granulated ingredients and triturates. It generates maximum revenue from India.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.77 | |||||
Interest Coverage | 29.19 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 31.76 | |||||
Beneish M-Score | 1.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.9 | |||||
3-Year EBITDA Growth Rate | 37.2 | |||||
3-Year EPS without NRI Growth Rate | 40.8 | |||||
3-Year Book Growth Rate | 58.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.11 | |||||
9-Day RSI | 45.39 | |||||
14-Day RSI | 50.78 | |||||
3-1 Month Momentum % | 29.58 | |||||
6-1 Month Momentum % | 77.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.09 | |||||
Quick Ratio | 2.02 | |||||
Cash Ratio | 0.57 | |||||
Days Inventory | 338.54 | |||||
Days Sales Outstanding | 142.43 | |||||
Days Payable | 126.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.13 | |||||
Forward Dividend Yield % | 0.13 | |||||
5-Year Yield-on-Cost % | 0.14 | |||||
Shareholder Yield % | 0.03 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.78 | |||||
Operating Margin % | 32.31 | |||||
Net Margin % | 26.69 | |||||
EBITDA Margin % | 38.25 | |||||
FCF Margin % | -8.37 | |||||
OCF Margin % | 9.12 | |||||
ROE % | 19.96 | |||||
ROA % | 14.59 | |||||
ROIC % | 16.05 | |||||
3-Year ROIIC % | 14.8 | |||||
ROC (Joel Greenblatt) % | 26.07 | |||||
ROCE % | 24.52 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 95.76 | |||||
Forward PE Ratio | 48.34 | |||||
PE Ratio without NRI | 95.67 | |||||
PS Ratio | 25.14 | |||||
PB Ratio | 14.76 | |||||
Price-to-Tangible-Book | 16.14 | |||||
EV-to-EBIT | 71.01 | |||||
EV-to-EBITDA | 66.76 | |||||
EV-to-Revenue | 25.53 | |||||
EV-to-FCF | -680.56 | |||||
Price-to-Graham-Number | 7.4 | |||||
| Price-to-Net-Current-Asset-Value | 39.24 | |||||
Earnings Yield (Greenblatt) % | 1.41 | |||||
FCF Yield % | -0.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sudeep Pharma Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,756.11 | ||
| EPS (TTM) (₹) | 16.17 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 50.78 | ||
| 14-Day ATR (₹) | 67.098 | ||
| 20-Day SMA (₹) | 1197.31 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 524.95 - 1376 | ||
| Shares Outstanding (Mil) | 112.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sudeep Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sudeep Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.500000 Cash Dividend | 2026-07-23 | 851.05 (-2.73%) |
Show
Entries
Sudeep Pharma Ltd Frequently Asked Questions
What is Sudeep Pharma Ltd(BOM:544619)'s stock price today?
The current price of BOM:544619 is ₹1154.95. The 52 week high of BOM:544619 is ₹1376.00 and 52 week low is ₹524.95.
When is next earnings date of Sudeep Pharma Ltd(BOM:544619)?
The next earnings date of Sudeep Pharma Ltd(BOM:544619) is .
Does Sudeep Pharma Ltd(BOM:544619) pay dividends? If so, how much?
The Dividend Yield %  of Sudeep Pharma Ltd(BOM:544619) is 0.13% (As of Today), Highest Dividend Payout Ratio of Sudeep Pharma Ltd(BOM:544619) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Sudeep Pharma Ltd(BOM:544619) is 0.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers